Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
FOXO4-DRI acts as a competitive inhibitor of this interaction binding directly to the transactivation domain 2 (TAD2) of p53, displacing FOXO4, and allowing phosphorylated p53 to be exported from the nucleus and directed to mitochondria, where it activates BAX, triggers caspase-3 cleavage (via the p53/BCL-2/Caspase-3 signalling pathway), and drives cell-intrinsic apoptosis
The BPC157 + TB500 + GHK-Cu Glow Blend can be used in laboratory and preclinical designs such as: These use cases reflect research environments where defined peptide blends contribute to structured exploratory workflows
These injections contain ingredients that include essential nutrients, vitamins, and amino acids that work together to enhance liver function and optimize fat metabolism
July 9 Product: Arcutis Biotherapeutics Zoryve Indication: Atopic dermatitis Arcutis Biotherapeutics won its third indication in two years for Zoryve, as the FDA green lit the topical cream to treat adults and children six years and older with atopic dermatitis
US$ 21.41
US$ 26.01
US$ 26.20
US$ 24.25